Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Tinley Park › NPI 1831373836
Lab

Hematogenix Laboratory Services, LLC

Hematogenix Laboratory Services, LLC was paid $832K by Medicaid between Jan 2018 and Sep 2024, across 20 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 67% of everything it billed.

33Billing provider infoHEMATOGENIX LABORATORY SERVICES, LLC
TINLEY PARK, IL 60487
33aNPI1831373836assigned 12/27/2007
28Total paid$832K
24GClaims17,851
24DCodes billed20
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Illinois

Rank by total paid#77 of 235
Median peer was paid$123K
This provider vs. median6.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018788$9K
2019773$20K
20202,321$140K
202110,317$523K
20223,004$128K
2023487$8K
2024incomplete161$5K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 67% 6,585 5,533 $555K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 14% 4,998 4,182 $113K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 8.1% 2,731 2,371 $67K
88185 6.8% 627 571 $57K
88189 1.5% 839 760 $12K
88377 1.2% 151 131 $10K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 650 535 $5K
88184 <1% 632 575 $5K
86769 <1% 37 29 $2K
88342 <1% 416 371 $2K
88341 <1% 30 25 $2K
88313 <1% 25 24 $842.50
8 more codes
88237 <1% 12 $458.83
85097 <1% 25 $369.74
81219 <1% 15 $192.64
81270 <1% 15 $145.18
81339 <1% 15 $108.12
88311 <1% 15 $48.99
88291 <1% 12 $39.61
81206 0% 21 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAL-MASRI, HYTHAM (PRESIDENT)